MRNA Moderna, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Moderna (MRNA) Stock: Buy, Sell, or Hold?

$195.00
-4.33 (-2.17%) ▼
5d: -12.7% 30d: -3.77% 90d: +40.4%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (47%)
Quality Score
44/100
Position
OVERSOLD
30-Day Fair Range
$204.80 – $244.10
Position: OVERSOLD
Forward P/E & Valuation
-43.9x
Next 12M consensus est.
Wall Street Target
$164.53
-15.6% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$189.98 / $280.80
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: MRNA is down 12.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Sector Domino Phase 3: Active Cascade Score 73/100 · Biotechnology & Emerging Therapeutics (XBI)
View Full Sector Domino & 3-Stack Radar →
Washout Constructive Signal: Deeply oversold on subdued volume inside a washed-out peer group — contrarian seller-exhaustion watch.
-27.5% vs 60d high · 0.95x relative volume

Get Alerted When MRNA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: MRNA is currently trading at $195.00, which is considered oversold relative to its 30-day fair value range of $204.80 to $244.10.

Technical Outlook: Technically, MRNA is in a strong uptrend. The price is currently testing key support at $189.98. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: MRNA scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $164.53. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $204.80 - $244.10
Company Quality Score 44/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 47.4%

Trading Range & Key Levels

30-Day Trading Range $204.80 - $244.10
Current vs Trading Range OVERSOLD
Support Level $189.98
Resistance Level $280.80
Current Trend Strong Uptrend
Technical data as of Nov 20, 2026
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $215.27 · IV 83.7%

MRNA Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($21,527)

Compare $21,527 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 83.7% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $220 / $260 Bull Call Spread

Buy 1x $220C · Sell 1x $260C · 32d

Net Entry $1,105 Debit
T+5d @ +5% Move +$267 (+24%)
Max Risk / Buffer $1,105 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $190 / $180 Bull Put Spread

Sell 1x $190P · Buy 1x $180P · 32d

Net Entry $255 Credit
Max Credit / Yield +$255 (+34.2% RoM)
Max Risk / Buffer -12.9% Cushion ($745 Mgn)
5d Edge & Liquidity 74% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $190P / $220-$260C Seagull

Sell 1x $190P · Buy 1x $220/$260C · 32d

Net Entry $140 Debit
T+5d @ +5% Move +$693 (+23.1% RoM)
Max Risk / Buffer -11.7% Put Cushion ($3,005 Mgn)
5d Edge & Liquidity 1.1x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Protect Your Profits

Holding MRNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Active Quantitative Risk Vetoes (1)
Attention Chase Risk: msg spike z=2.3 (105 vs ~42/day), 5d move +14.6%
Phase & Gamma Walls CONSOLIDATION
Days in Phase: 22d (50% conf)
Put Wall / Support: $190 (8,539 OI)
Call Wall / Resist: $200 (11,509 OI)
Technical Setup Structure ACTIVE SETUP
Absorption: Active (CMF 0.01)
Pullback / Drawdown: -27.5% from 52W High
Consolidation: Trending (ADX 28.7)
13F Whale Fund Buying 1 Funds
Baillie Gifford NEW POSITION $668.9M
30D Insider Cluster Signal TRACKED
30D Insider Buyers: 0 insiders ($0)
30D Net Insider Flow: $-16,900,019

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading 15.6% above Wall St target ($164.53)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -43.85
Wall Street Target $164.53 (-15.6%)
Revenue Growth (YoY) 29.2%
Earnings Growth (YoY) -85.1%
Profit Margin -110.5%
Share MRNA Analysis

Share this live MRNA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (MRNA)

Bearish 3 Retail Mentions
Reddit / WSB Comments
1
Bearish
Retail Stream Volume
2 msgs
24h retail stream
Last Tracked
Nov 21, 2026
Daily AI digest
AI Retail Discussion Summary: Moderna stock faces potential losses if its cancer vaccine with Merck underperforms, with the share price currently trading at a high valuation. The setback would not significantly impact sales, as the vaccine is not yet approved.
Key Retail Themes: Valuation Cancer Vaccine
Aggregated from r/wallstreetbets, r/stocks & retail trader streams. View All Trending Reddit & WSB Stocks →
Last updated: November 21, 2026 4:47 AM ET
Data refreshes hourly during market hours. Next update: 5:47 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MRNA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
24 analysts
$275 58 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 38 SELL
JANX
Janux Therapeutics Inc
STRONG BUY
18 analysts
$33 53 HOLD
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
18 analysts
$72 37 SELL
SNDX
Syndax Pharmaceuticals I…
STRONG BUY
12 analysts
$35 61 BUY

Advanced MRNA Option Strategies

Professional options setups generated by AI based on today's MRNA price and gamma walls.

Iron Condor Bull Call Bear Put Collar
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals